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Background: Recent success of disease-specific therapy is expected to improve prognosis of patients with Eisenmenger syndrome(ES), however, 
sudden death(SD) is a major cause of death in ES. Our aim is to clarify predictive factors for sudden death in these patients in current era.
Methods: Data regarding patient characteristic, function class, percutaneous Oxygen saturation (SpO2), electrocardiographic, echocardiographic, 
laboratory parameters, arrhythmia and systemic complications and medication were collected in 104 patients (male 46,16-66 yrs) with ES who 
visited outpatient clinic in 14 participated institutes from 1998 to 2009.Clinical data between SD group and non SD group were compared, and 
prognostic factors for SD were analyzed.
Results: During a median follow-up of 15 yrs, sixteen patients died; SD in 8 (50%) and heart failure in 3 (19%). Causes of SD were unknown (5), 
ventricular fibrillation(2)and pulmonary haemorrhage(1). In SD group, mean value of SPO2 was lower (76% vs 85%, p=0.001), arrhythmia was more 
frequent than non SD group (50% vs 19%, p=0.07). However, there were no differences regarding number of NYHA functional class>2 (62% vs 
35%,p=0.14), hemoptysis (12% vs 19%,p=0.6), taking bosentan and/or sildenafil (13% vs 29%,p=0.27) In multivariate analysis, SpO2<80% was 
only factor independently related to sudden death (RR 7.3, p=0.005).
Conclusions: Even in current era of disease-specific therapy, sudden death was still a main cause of death in Eisenmenger syndrome. To prevent 
sudden death, meticulous care and close follow-up for hypoxia and arrhythmia is necessary.
